ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "meta-analysis"

  • Abstract Number: 2367 • 2017 ACR/ARHP Annual Meeting

    The Effect of Glucocorticoids on Bone Mineral Density in Patients with Rheumatoid Arthritis:  a Systematic Review and Meta-Analysis

    Anne-Birgitte Blavnsfeldt1,2, Malissa Dawn Thomsen3, Simon Tarp4, Bente Langdahl2,5, Ellen-Margrethe Hauge2,6 and Annette de Thurah7,8, 1Rheumatology, Aarhus Universityhospital, Aarhus C, Denmark, 2Department of Clinical Medicine, Aarhus University, Aarhus C, Denmark, 3Diagnostic Centre, Silkeborg Regional Hospital, Silkeborg, Denmark, 4The Parker Institute, Bispebjerg & Frederiksberg Hospital, Copenhagen, Denmark, 5Endocrinology, Aarhus University Hospital, Aarhus, Denmark, 6Aarhus Universityhospital, Aarhus C, Denmark, 7Department of Rheumatology, Aarhus University Hospital, Aarhus, DK, Aarhus, Denmark, 8Department of Clinical Medicine, Aarhus University, Aarhus, Denmark

    Background/Purpose: The role of glucocorticoids (GCs) in the treatment of rheumatoid arthritis (RA) is widely debated. GCs stimulate bone resorption and impair bone formation. Inflammatory…
  • Abstract Number: 2392 • 2017 ACR/ARHP Annual Meeting

    Impact of the Pattern of Interstitial Lung Disease on Mortality in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

    Namrata Singh1, Jimmy Varghese2, Bryant R. England3, Joshua J. Solomon4, Kaleb Michaud5, Ted R. Mikuls6 and Marin Schweizer7, 1Internal Medicine, University of Iowa Hospitals and Clinics and Iowa City VA, Iowa City, IA, 2Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, 3Division of Rheumatology & Immunology, Department of Internal Medicine, Nebraska-Western IA VA Health Care System & University of Nebraska Medical Center, Omaha, NE, 4Division of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, CO, 5University of Nebraska Medical Center, Omaha, NE, 6Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 7Internal Medicine, Iowa City VA, Iowa City, IA

    ABSTRACT Impact of the Pattern of Interstitial Lung Disease on Mortality in Rheumatoid Arthritis: A systematic review and meta-analysis Background/Purpose: Interstitial lung disease affects 10-15%…
  • Abstract Number: 2483 • 2017 ACR/ARHP Annual Meeting

    Cycling Versus Swapping in Patients with Rheumatoid Arthritis with an Inadequate Response to at Least One Tumor Necrosis Factor Alpha Inhibitor: A Systematic Review and Meta-Analysis of Observational Studies

    Maria A. Lopez-Olivo, Aliza Matusevich and Maria Suarez-Almazor, Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX

    Background/Purpose: In patients with rheumatoid arthritis (RA) who do not respond or lose response to a tumor necrosis factor inhibitor (TNFi), opinions are divided on…
  • Abstract Number: 2515 • 2017 ACR/ARHP Annual Meeting

    Prevalence and Risk Factors for Osteoporotic Fractures and Low Bone Mineral Density in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis

    Julio Ramírez1, Juan Carlos Nieto2, Rafael Curbelo3, Santos Castañeda4 and Loreto Carmona5, 1Rheumatology, Hospital Clínic, Barcelona, Spain, 2Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 3Instituto de Salud Musculoesquelética, Madrid, Spain, 4Hospital Universitario de La Princesa, Madrid. Spain, Madrid, Spain, 5Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain

    Background/Purpose: To describe the prevalence of osteoporosis (1), the prevalence and incidence of fractures (2), and the frequency of risk factors for low bone mineral…
  • Abstract Number: 463 • 2017 ACR/ARHP Annual Meeting

    Certolizumab Pegol for Fatigue in Chronic Inflammatory Rheumatic Diseases: A Meta-Analysis

    Yesim Ozguler1, Sinem Nihal Esatoglu1, Guzin Karatemiz1, Ali Ugur Unal2, Gul Guzelant1, Elif Dincses3, Mustafa Erdogan1, Sema Kaymaz Tahra2 and Gulen Hatemi1, 1Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 2Departement of Internal Medicine, Division of Rheumatology, Marmara University, Istanbul, Turkey, 3Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, İstanbul, Turkey

     Background/Purpose: Fatigue is an important problem that impairs life quality in patients with rheumatic diseases. Although fatigue is often associated with disease activity, only a…
  • Abstract Number: 531 • 2017 ACR/ARHP Annual Meeting

    Comparative Effectiveness of Tofacitinib Versus Baricitinib in Rheumatoid Arthritis Using a Systematic Review and Network Meta-Analysis of Randomized Trials

    Natalia Zamora1,2,3, Maria A. Lopez-Olivo1, Jean Tayar1, Robin Christensen2 and Maria Suarez-Almazor1, 1Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX, 2Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark, Copenhagen, Denmark, 3Reumatologia, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, Buenos Aires, Argentina

    Background/Purpose: To explore the comparative effectiveness of tofacitinib or baricitinib in patients with rheumatoid arthritis (RA) following a systematic review of randomized trials, by performing…
  • Abstract Number: 539 • 2017 ACR/ARHP Annual Meeting

    Comparison of Oral Versus Parenteral Methotrexate in Rheumatoid Arthritis: A Meta-Analysis

    Sahar Janjua1, Andreea Bujor1, Michael P. LaValley2, Josefina Duran3, Jürgen Braun4 and David T. Felson5, 1Department of Rheumatology, Boston Medical Center, Boston, MA, 2Boston University School of Public Health, Boston, MA, 3Pontificia Universidad Católica de Chile, Santiago, Chile, 4Institut für angewandte Statistik Dr. Jörg Schnitker GmbH, Bielefeld, Germany, 5Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: Methotrexate (MTX) is the mainstay first-line therapy for rheumatoid arthritis (RA), and it can be given orally or parenterally. Bioavailability of oral MTX may…
  • Abstract Number: 636 • 2017 ACR/ARHP Annual Meeting

    Effect of Adding MTX to TNF Inhibitors on Joint Severity Indices and Skin Scores in Psoriatic Arthritis: A Post-Hoc Meta-Analysis of Randomized, Controlled Trials

    Rochelle Castillo1, Khushboo Sheth2 and Santhanam Lakshminarayanan3, 1University of Connecticut, Farmington, CT, 2Rheumatology, Stanford University, Palo Alto, CA, 3Division of Rheumatology, University of Connecticut Health Center, Farmington, CT

    Background/Purpose: Co-medication of MTX with TNF inhibitors (TNFi) has proven superior to TNFi monotherapy in improving clinical outcomes in patients with RA. Whether this holds…
  • Abstract Number: 691 • 2017 ACR/ARHP Annual Meeting

    Serum Anti-NR2 Has a Better Specificity Than Sensitivity in Diagnosing Neuropsychiatric Systemic Lupus Erythematosus (NPSLE)

    Seyed-Foad Ahmadi1, Golara Zahmatkesh2, Masoud Majed3 and Sheetal Desai4, 1Department of Medicine, University of California Irvine, Orange, CA, 2Department of Psychiatry, Charles Drew University of Medicine and Science/UCLA, Los Angeles, CA, 3Division of Neuroimmunology, Mayo Clinic, Rochester, MN, 4Medicine/Rheumatology, Unviersity of California, Irvine, Orange, CA

    Background/Purpose: Anti-NR2, a subclass of anti-NMDA receptor antibodies, is reportedly associated with NPSLE syndromes. However, its diagnostic accuracy is inconsistent across prior studies. Hence, we…
  • Abstract Number: 786 • 2017 ACR/ARHP Annual Meeting

    Smoking As a Risk Factor for Giant Cell Arteritis: A Systematic Review and Meta-Analysis

    David Brennan1, Patompong Ungprasert2, Kenneth J. Warrington2 and Matthew J. Koster2, 1Internal Medicine, Mayo Clinic, Rochester, MN, 2Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose: Tobacco smoking is a well-established risk factor for the development of several autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus.  A similar…
  • Abstract Number: 896 • 2017 ACR/ARHP Annual Meeting

    The Steroid Tapering in ANCA Vasculitis Evaluation Study (STAVE) 2: A Systematic Review and Meta-Analysis

    Jennifer Rodrigues1, David Collister1, Amy Archer2, Kim Cheema3, Paul Alexander4, Christian Pagnoux5, Lehana Thabane4, Peter A. Merkel6, David Jayne7 and Michael Walsh1, 1Nephrology, McMaster University, Hamilton, ON, Canada, 2Rheumatology, Northwestern University, Chicago, IL, 3Nephrology, University of Calgary, Calgary, AB, Canada, 4Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada, 5Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 6Division of Rheumatology, University of Pennsylvania; Perelman School of Medicine, Philadelphia, PA, 7Vasculitis and Lupus Clinic, Department of Medicine, University of Cambridge, Cambridge, United Kingdom

    Background/Purpose: Relapses of ANCA-associated vasculitis (AAV) are associated with death, decreased renal function, and end-stage renal disease.  Whether longer-term treatment with glucocorticoids (GC) reduces the…
  • Abstract Number: 617 • 2016 ACR/ARHP Annual Meeting

    Therapy in Patients with Rheumatoid Arthritis (RA) with Inadequate Response to Tumor Necrosis Factor Alpha Inhibitors (TNFi): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs

    Maria A. Lopez-Olivo1, Aliza Matusevich2,3 and Maria Suarez-Almazor4, 1Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine,The University of Texas MD Anderson Cancer Center, Houston, Texas, USA,, Houston, TX, 2General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 3The University of Texas, School of Public Health, Houston, TX, 4Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Houston, TX

    Background/Purpose: Up to one-third of the patients who receive TNFi lose responsiveness over time. Options available to these patients include treatment with an alternative TNFi…
  • Abstract Number: 1155 • 2016 ACR/ARHP Annual Meeting

    The Effect of Nurse-Led Follow-up in Rheumatoid Arthritis. a Systematic Review and Meta-Analysis of Randomized Controlled Trails

    Annette de Thurah1,2, Bente Appel Esbensen3,4, Ida K Roelsgaard4, Tove F Frandsen5 and Jette Primdahl6,7, 1Department of Rheumatology, Aarhus University Hospital, Aarhus, DK, Aarhus, Denmark, 2Department of Clinical Medicine, Aarhus University, Aarhus, DK, Aarhus N, Denmark, 3Copenhagen Center for Arthritis Research (Copecare), Rigshospitalet, Copenhagen, DK, Copenhagen, Denmark, 4Department of Clinical Medicine, University of Copenhagen, Copenhagen, DK, Copenhagen, Denmark, 5The knowledge Center of Odense University Hospital, Odense University Hospital, Odense, DK, Odense, Denmark, 6King Christian X’s Hospital for Rheumatic Diseases, Graasten, Hospital of Southern Jutland, DK, Graasten, Denmark, 7Institute for Regional health Research, University of Southern Denmark, Odense, DK, Odence, Denmark

    Background/Purpose: Due to a longer life expectancy in general, the treatment burden of RA is growing, and although treatment is generally becoming more effective and…
  • Abstract Number: 1206 • 2016 ACR/ARHP Annual Meeting

    A Replication Study and Meta-Analysis Demonstrate the Influence of the mtDNA Haplogroups in the Rate of Incident Knee Osteoarthritis. Functional Explanation of This Association Using Transmitochondrial Cybrids

    Ignacio Rego-Pérez1, Mercedes Fernandez Moreno1, Angel Soto-Hermida1, Maria Eugenia Vazquez Mosquera1, Estefanía Cortés-Pereira1, Sara Relaño-Fernandez2, Tamara Hermida-Gómez3, Sonia Pertega4, Rafael Garesse5, Natividad Oreiro3, Carlos Fernandez-Lopez1 and Francisco J. Blanco1,6, 1Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo HospitalarioUniversitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 2Plataforma de Genómica. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 3Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 4Unidad de Epidemiología Clínica y Bioestadística. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 5Departamento de Bioquímica, Instituto de Investigaciones Biomédicas "Alberto Sols" UAM-CSIC y Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidad Autónoma de Madrid 28029, Madrid, Spain, Madrid, Spain, 6Rheumatology Division, INIBIC-Complejo Hospitalario Universitario A Coruña (CHUAC), La Coruña, Spain

    Background/Purpose: The study of the mitochondria in the context of osteoarthritis (OA) attracted much attention. In this study we aimed to evaluate the influence of…
  • Abstract Number: 1212 • 2016 ACR/ARHP Annual Meeting

    A Combined Large Scale Meta-Analysis Identifies COG6 As a Novel Shared Risk Locus for Rheumatoid Arthritis and Systemic Lupus Erythematosus

    Ana Márquez1, Laura Vidal-Bralo2, Luis Rodriguez-Rodriguez3, Miguel Angel González-Gay4, Alejandro Balsa5, Isidoro Gonzalez-Alvaro6, Patricia Carreira7, Norberto Ortego Centeno8, Maria del Mar Ayala Gutierrez9, Francisco José García-Hernández10, Francisca González Escribano11, José Mario Sabio12, Carles Tolosa13, Ana Suárez14, Antonio Gonzalez15, Leonid Padyukov16, Jane Worthington17, Timothy J. Vyse18,19, Marta E. Alarcon Riquelme20,21 and Javier Martín1, 1Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, PTS-Granada, Granada, Spain, 2Instituto Investigacion Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain, 3Rheumatology Department and Heath Research Institute (IdISSC), Hospital Clinico San Carlos, Madrid, Spain, 4Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, Santander, Spain, 5Department of Rheumatology and Institute for Health Research (IdiPAZ), University Hospital La Paz, Madrid, Spain, 6Rheumatology, Rheumatology Service, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain, 7Department of Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, 8Systemic Autoimmune Diseases Unit, Hospital Clínico San Cecilio, Granada, Spain, 9Department of Internal Medicine, Hospital Carlos Haya, Málaga, Spain, 10Department of Internal Medicine, Hospital Universitario Virgen del Rocío, Sevilla, Spain, 11Department of Immunology, Hospital Universitario Virgen del Rocío (IBiS, CSIC, US), Sevilla, Spain, 12Department of Internal Medicine, Hospital Virgen de las Nieves, Granada, Spain, 13Department of Internal Medicine, Hospital Parc Taulí, Sabadell, Spain, 14Department of Functional Biology, Immunology Area, Faculty of Medicine, University of Oviedo, Oviedo, Spain, 15Laboratorio de Investigación 10 and Rheumatology Unit, Instituto de Investigación Sanitaria - Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain, 16Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 17Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 18Department of Medical and Molecular Genetics, King's College London, London, United Kingdom, 19Division of Immunology, Infection and Inflammatory Disease, King’s College London, London, United Kingdom, 20Centro de Genómica e Investigación Oncológica (GENYO), Pfizer-Universidad de Granada-Junta de Andalucía, Granada, Spain, 21Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: One of the main limitations of the association studies in autoimmunity is the difficulty in identifying genetic risk variants with modest effects, given the…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology